Genefic Announces Opening of New Corporate Headquarters in Northern San Diego County

Rancho Bernardo facility will play a significant role in Dalrada Corporation’s newly-redesigned operating structure to support growth within the healthcare market.

SAN DIEGO--(BUSINESS WIRE)--Dalrada Financial Corporation (OTCQB: DFCO, “Dalrada”), a problem-solving innovator that takes on complex, multi-disciplinary challenges in healthcare, clean energy, precision manufacturing, and technology, announced today that its healthcare division, Genefic, will open a new location in north county San Diego that will serve as Genefic’s offices and corporate headquarters.

The new facility – a two-story, nearly 8,500 square-foot standalone building in Rancho Bernardo’s Montadura Business Park, features multiple private offices and conference rooms and offers easy access to and from the I-15 freeway, a primary roadway for southern California.

The building will be a multi-purpose office space for all Genefic brands and divisions as well as the working center for the executive management team. It will also include dedicated space for the company’s laboratory and pharmacy services and is expected to host nursing and healthcare education classes for Genefic’s career college. Additionally, the facility will be the main control center for the company’s health and wellness clinics.

“We are excited to strengthen Genefic’s presence in Southern California and make Rancho Bernardo our official headquarters,” said Harvey Hershkowitz, Genefic Chairman and Chief Executive Officer. “This new location will allow our team to come together and focus on furthering our product and technology development specifically designed for the healthcare industry, while continuing our commitment to improving health outcomes for people around the world through reimagined patient care.”

The company expects to be fully moved into the new facility and begin normal operations later this month. For more information about Genefic’s products and services, please visit www.genefic.com.

About Dalrada Financial Corporation

Dalrada Financial Corporation (OTCQB: DFCO) is a forward-facing organization that continually produces disruptive products and services that accelerate positive change for current and future generations.

Since 1982, Dalrada has redefined possibilities while boldly addressing global challenges with transformative innovations that drive targeted advances in emerging markets for a new era of human behavior and interaction, ensuring a bright future for the world around us.

Dalrada Financial Corporation is committed to positively impacting people, businesses, and the planet through sustainable solutions. For more information, please visit www.dalrada.com, and follow us on LinkedIn, Facebook, and Twitter.

About Genefic

With a dedicated commitment to health and wellness and improved patient care, Genefic delivers with bold ingenuity. Genefic creates key products and services and builds comprehensive solutions that provide better outcomes through reimagined healthcare systems. From virus and disease screening capabilities to pharmaceutical goods and holistic wellness clinics, Genefic creates health innovations that make positive impacts around the world. To learn more, visit www.genefic.com.

Disclaimer

Statements in this press release are not historical facts. The statements are forward-looking, including statements regarding future revenues and sales projections, plans for future financing, the ability to meet operational milestones, marketing arrangements and plans, and shipments to and regulatory approvals in international markets. Such statements reflect management’s current views, are based on certain assumptions, and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors and will be dependent upon a variety of factors including, but not limited to, our ability to obtain additional financing that will allow us to continue our current and future operations and whether demand for our products and services in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company’s expectations regarding these forward-looking statements or the occurrence of unanticipated events. Factors that may impact the Company’s success are more fully disclosed in the Company’s most recent public filings with the US Securities and Exchange Commission (“SEC”), including its annual report on Form 10-K.

Michael Eslinger (meslinger@dalrada.com)